IMA Life strengthens partnership with Sharp Sterile Manufacturing through advanced aseptic technology
Date: January 15, 2026 | Category: Packaging
IMA Life, one of the three pharma divisions of IMA Group and global leader in aseptic processing and freeze-drying solutions, is pleased to announce its contribution to Sharp Sterile Manufacturing’s expansion project in Lee, Massachusetts.
IMA Life, a global leader in aseptic processing and freeze-drying solutions, is proud to support Sharp Sterile Manufacturing as part of its recent $28 million expansion of the Lee, Massachusetts facility. This strategic investment includes the installation of a fully automated IMA Life isolated filling line for Ready-To-Use vials, marking a significant milestone in advancing sterile manufacturing capabilities in the U.S.
The new system integrates cutting-edge robotics, non-destructive weight checks, and a state-of-the-art lyophilizer, enabling Sharp Sterile to efficiently produce batches of up to 100,000 units. By more than doubling the site’s filling capacity, this technology will help pharmaceutical partners accelerate the delivery of critical therapies to patients worldwide.
IMA Life continues to lead the way in aseptic processing and freeze-drying technologies, offering tailored solutions to meet the evolving needs of the pharmaceutical industry.
About Sharp Sterile Manufacturing
About IMA Life
IMA Life, part of the IMA Group, is a leading provider of advanced aseptic processing and freeze-drying solutions for the pharmaceutical sector. The company’s comprehensive range of products and services supports pharmaceutical companies in achieving high-quality, efficient, and reliable manufacturing processes on a global scale. With decades of expertise, IMA Life remains at the forefront of innovation in pharmaceutical production, offering tailored solutions that meet the unique needs of each client.
PRESS RELEASE
Immagini news:
